US 8796428
Erk1/2 posphorylation site specific antibody
granted A61PA61P35/04A61P9/00
Quick answer
US patent 8796428 (Erk1/2 posphorylation site specific antibody) held by Julius-Maximilians-Universitat Wurzburg expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Julius-Maximilians-Universitat Wurzburg
- Grant date
- Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P35/04, A61P9/00